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Dermatophytoses (ringworms) are among the most frequent skin infections and are a
highly prevalent cause of human disease worldwide. Despite the incidence of these
superficial mycoses in healthy people and the compelling evidence on chronic and deep
infections in immunocompromised individuals, the mechanisms controlling dermatophyte
invasion in the skin are scarcely known. In the last years, the association between certain
primary immunodeficiencies and the susceptibility to severe dermatophytosis as well as
the evidence provided by novel experimental models mimicking human disease have
significantly contributed to deciphering the basic immunological mechanisms against
dermatophytes. In this review, we outline the current knowledge on fungal virulence
factors involved in the pathogenesis of dermatophytoses and recent evidence from
human infections and experimental models that shed light on the cells and molecules
involved in the antifungal cutaneous immune response. The latest highlights emphasize
the contribution of C-type lectin receptors signaling and the cellular immune response
mediated by IL-17 and IFN-g in the anti-dermatophytic defense and skin
inflammation control.
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The skin is the most extensive organ of the body, is an ecological niche for microbiota and the first
barrier against aggression from environmental noxa and pathogenic microorganisms. Not only is a
physical barrier but also a dynamic system constituted by the skin resident immune system that is crucial
to control an infection, resolve damage, or maintain tissue homeostasis. Among the most frequent
human skin infections, dermatophytoses (ringworms) represent the fourth cause of disease with a global
incidence estimated in 20 to 25% within the healthy population (1–3). These infections are caused by
filamentous fungi, ancestrally digesters of soil keratin, that have adapted to the keratinized tissue of
mammals, and became parasitic microorganisms to animals and humans. Therefore, dermatophytoses
are characterized by hyphae superficial invasion into the skin, hair, and nails causing subacute or chronic
infections with different inflammation degrees among immunocompetent individuals (Figure 1). Recent
taxonomic changes classify dermatophytes into five genera: Epidermophyton, Trichophyton,org December 2020 | Volume 11 | Article 6056441
Burstein et al. Skin Antifungal ImmunityMicrosporum, Arthroderma, and Nannizzia (4) and, among them,
there are different species adapted to particular ecological niches and
hosts which led to the classification in geophilic, zoophilic and
anthropophilic fungi. Anthropophilic species (Trichophyton
rubrum, Epidermophyton floccosum) are well adapted to humans
and often cause chronic infections with mild clinical symptoms. In
contrast, dermatophytes from animals (Microsporum canis,
Trichophyton/Arthroderma benhamiae, Trichophyton
mentagrophytes, etc.) or soil (Nannizzia gypsea/MicrosporumFrontiers in Immunology | www.frontiersin.org 2gypseum) are frequently isolated from patients suffering from mild
to highly inflammatory dermatophytosis but with lesions that are
prone to spontaneous resolution (5) (Figure 1). In contrast, the
immunosuppressed population (especially cell-mediated immunity
deficiency settings such as HIV-AIDS, transplant, neoplasia,
diabetes, or corticosteroid therapy) is particularly susceptible to
these infections showing extensive superficial lesions that are often
unresponsive to conventional antifungal treatment (3, 6, 7). This







FIGURE 1 | Human and experimental dermatophytosis (A, B). Superficial mild inflammatory infections in humans by M. canis (A) tinea corporis and (B) tinea capitis
by M. canis (C–F). Inflammatory human dermatophytosis (C): inflammatory tinea capitis (Kerion de Celsi) by T. mentagrophytes and (D) deep infection of the scalp
by M. canis (ref. 106) showing hyphae in dermis (E) stained with PAS-hematoxylin or (F) Grocott-Gomori’s methenamine silver (GMS) staining (200x magnification)
(G–J). Experimental dermatophytosis after epicutaneous infection of (G, H) wild-type (WT) or (I, J) IL-17RA-deficient C57BL/6 mice with M. canis (8 days post-infection)
(ref. 51) (G). Mild inflammatory lesions and (H) histopathology showing PAS-positive hyphae invading the stratum corneum and hair follicles in WT (I). Highly inflammatory
lesions and (J) histopathology showing extensive superficial fungal proliferation in IL-17RA-deficient mice. Arrows: M. canis hyphae. Asterix: inflammatory reaction (400x
magnification). All images are property of Chiapello’s lab.December 2020 | Volume 11 | Article 605644
Burstein et al. Skin Antifungal Immunityin treatment-recalcitrant, recurrent and chronic dermatophytosis
probably due to indiscriminate use of antibiotics and corticosteroid
drug combination (8).
Despite the high incidence of dermatophytosis in healthy people
as well as the complications of these infections in
immunocompromised individuals, the immune mechanisms that
control dermatophyte invasion are less known and studied than
those involved in other fungal diseases. In the last years, the
identification of genetic mutations in patients with primary
immunodeficiencies associated with severe deep or widespread
dermatophytosis and the development of experimental models
that mimic human infection have contributed to deciphering the
basic mechanisms of cutaneous immunity against dermatophytes.
Taking into account the recent evidence from human infections and
experimental models, in this review we discuss the latest advances in
the knowledge and state-of-the-art of innate and adaptive
mechanisms of the immune response against dermatophyte fungi.DERMATOPHYTE VIRULENCE FACTORS
In order to degrade keratin, dermatophytes secrete an arsenal of
hydrolytic enzymes (proteases) which are assumed to be the main
virulence factors in live tissue infection (9). It is known that the
pathogenesis of dermatophytosis includes several stages (i.e. fungal
adhesion, germination, invasion, penetration) associated with the
secretion of enzymes to degrade skin components (10–12) (Table
1). Although there is a common understanding that dermatophyte
keratinases are of major relevance for pathogenicity, the entire
process of host adaptation during infection seems to be quite
complex (15).Frontiers in Immunology | www.frontiersin.org 3The colonization by anthropophilic species in humans or
zoophilic species in animals usually causes asymptomatic
infections or, eventually, chronic infections with minimal
inflammation response suggesting a specific adaptation to the
host probably in favor of survival and transmission. On the
contrary, human infections with geophilic or zoophilic
dermatophytes occur with inflammatory-associated symptoms
and, generally, self-resolve (Figure 1). Therefore, depending on
the host and the infective species, dermatophytes might
differentially express virulence factors and activate, or suppress,
particular immune receptors and signaling pathways that eventually
would determine their own persistence or elimination. Comparative
genome studies in various dermatophyte species have revealed that
there are few differences in gene regulation and post-transcriptional
mechanisms among them, but whether those differences might be
responsible for the host-specific adaptation remains largely
unknown (26).
Several dermatophyte enzymes and proteins participate in the
keratin degradation and keratinolytic proteases activity
culminates in the onset and maintenance of the infection
process (9, 26). However, the virulence factors that are
particularly related to pathogenicity degree and host adaptation
have not been precisely identified yet. In the process of keratin
degradation by dermatophytes, Graser et al. (12) have described
three consecutive steps: first, the sulfitolysis stage [e.g., mediated
by cysteine dioxygenases (20)], that liberates sulfites that reduce
cysteine disulfuric bridges of the compact keratin in the stratum
corneum should be in cursive to produce polypeptidic soluble
chains that can be sliced by endoproteases. Second, endoproteases
activity (subtilisins, deuterolysins, and fungalysins) liberates long
peptides that are substrate to exoproteases (nonspecific amino- or
carboxypeptidase, and prolyl peptidases) which, finally, transformTABLE 1 | Virulence factors of dermatophytes.
Virulence factor Description and function References
Subtilisin-like proteases (Sub) Endoprotease activity in keratin digestion.
Reported as allergens and involved in immune response induction.
Woodfolk et al. (13). Gao and Takashima (14).
Burmester et al. (15). Eymann et al. (16).
Karami Robati et al. (17).




Endoprotease activity in keratin digestion. Burmester et al. (15). Eymann et al. (16).
Leucinaminopeptidases (Lap) Exoprotease activity in keratin digestion. Burmester et al. (15). Eymann et al. (16).
Dipeptidyl peptidases (Dpp) Exoprotease activity in keratin digestion. Burmester et al. (15). Eymann et al. (16).
Secondary metabolite production-
associated enzymes
Polyketide synthase and non-ribosomal peptide synthetase. Burmester et al. (15).
Martıńez et al. (19).
Cysteine dioxygenases Sulfitolysis of keratin. Involved in triggering humoral immune response during
infection.
Grumbt et al. (20). Eymann et al. (16). Reviewed
in Mercer and Stewart (9).
Hydrophobins Hydrophobin rodlet layer on conidial surface. Related to avoiding immune
recognition by neutrophils.
Heddergott et al. (21).
Eymann et al. (16).
Extracellular vesicles Unknown cargo, probably virulence factors. Related with modulation of the host
response.
Bitencourt et al. (22)
LysM proteins Protein domains related to binding to skin glycoproteins. Possibly involved in
immune evasion.
Martinez et al. (19). Kar et al. (23)
Heat shock proteins Hsp 30, Hsp60, Hsp70. Associated with adaptation to human temperature,
keratin digestion.
Reviewed in Martinez-Rossi et al. (24).
Other hydrolases and cell wall
remodeling-associated enzymes.
Lipases, glucanases, chitinases, betaglusidases, mannosyl transferases. Many
involved in triggering humoral immune response during infection.
Burmester et al. (15).
Martıńez et al. (19).
Eymann et al. (16). Martins et al. (25).December 2020 | Volume 11 | Article 605644
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effectively assimilated by hyphae. Supporting this, Burmester et al.
(15) analyzed the secretome of Arthroderma benhamiae after in
vitro growth on keratin and revealed that about 75% of secreted
proteins were proteases (subtilisin-like serine proteases: Sub3,
Sub4, and Sub7; fungalysine-type metalloproteases: Mep1,
Mep3, and Mep4; leucine aminopeptidases: Lap1 and Lap2;
dipeptidyl-peptidases: DppIV and DppV) with the remaining
formed by hydrolases and proteins involved in carbohydrate
metabolism. Consistently, subtilisin proteases genes expression
was detected on 93% of dermatophytes isolated from human
patients (17) and, in particular, subtilisin 6 (Sub6) has been
reported as the main protease secreted by Trichophyton
mentagrophytes during guinea pig infection and human
onychomycosis (14, 18). Also, Sub6 was detected in clinical
samples infected with Trichophyton rubrum and it was one of
the main allergens that produce an IgE-mediated response in
susceptible hosts (5, 13). In this regard, exoproteome analysis of
three Trichophyton species more frequently isolated from patients
(T. rubrum, T. interdigitale and A. benhamiae) showed that, at
least, 31 proteases (peptidases, oxide-reductases and beta-
glucosidases) were recognized by antibodies in patients’ sera,
indicating that these proteins are antigens involved in triggering
humoral immune response during infection (14, 16) (Table 1).
The ability of fungal-derived proteases to interfere with the
host immune response has been demonstrated for other human
pathogens. For instance, a metalloprotease released from A.
fumigatus conidia facilitates early fungal immune evasion by
cleaving complement proteins in the human host (27).
Moreover, Candida albicans secretes aspartic proteases, that
cleave pro-interleukin (IL)-1b to its biologically active form IL-
1b (27) and promote inflammation, as well as candidalysin, a
peptide toxin that damages epithelial membranes and triggers a
danger response signaling pathway (28). Whether similar
phenomena are also mediated by dermatophytes proteases is
currently unknown.
On the other hand, the experimental evidence also suggests
that dermatophyte pathogenesis involves mechanisms beyond
the fungal machinery used for keratin degradation, including
virulence factors like cell wall components and secreted products
(Table 1). In this regard, the transcriptome profile analysis of A.
benhamiae after in vitro interaction with human keratinocytes
revealed that not only proteases were found to be differentially
regulated but also genes associated with the synthesis of
secondary metabolism molecules (polyketide synthase and
non-ribosomal peptide synthetase), lipases and hydrophobin
(hypA) (15). In a similar way to RodA hydrophobin of
Aspergillus fumigatus (29), the hypA protein of A. benhamiae
forms a hydrophobic rodlet layer that enables conidia to avoid
recognition by immune cells at an early stage of infection (21).
Furthermore, other genes associated to the host-fungi
interaction, mainly through genomic and/or transcriptomic
analysis, were proposed: genes related to heat shock proteins
(24), other enzymes that participate in keratin degradation
(hydrolases, glucanases, chitinases, mannosyl transferases) (25),
ergosterol metabolism and reproduction, and LysM domainFrontiers in Immunology | www.frontiersin.org 4proteins (19, 23). Strikingly, various of these virulence factors
might be transported to the extracellular space by extracellular
vesicles (EVs), as it was demonstrated that T. interdigitale
produces these structures in vitro (22).
Therefore, the dermatophyte molecules that drive skin invasion,
trigger inflammation, or facilitate evasion during the infection
process still remain poorly understood. Further comprehensive
research on dermatophyte virulence factors is necessary to identify
the main microbial mechanisms that mediate difficult-to-treat
chronic infections or overly inflammatory responses.DERMATOPHYTE RECOGNITION AND
ACTIVATION OF THE INNATE IMMUNE
SYSTEM
Immune and non-immune cells sense fungi through their cell
wall components (i.e. polysaccharides, glycoproteins), secreted
extracellular molecules (i.e. peptide toxins) or intracellular
content (i.e. DNA) through different pattern recognition
receptors (PRR) which, upon ligation, transduce intracellular
signals that promote fungal phagocytosis, respiratory burst,
cytokines and chemokines release, phagocyte lysis, among
others, and thereby shape immune responses (30, 31). PRR can
be classified based on their structure and function: C-type Lectin
Receptors (CLR), Toll-like Receptors (TLR), Nucleotide-binding
and Oligomerization Domain (NOD)-like receptors (NLR), and
Retinoic acid Inducible Gene (RIG)-like receptors (RLR). Until
now, signaling pathways mediated by CLR, TLR and NLR have
been described in the interaction with dermatophytes and are key
modulators of host antifungal immunity.
C-Type Lectin Receptors
C-type Lectin Receptors (CLR) comprise a superfamily of soluble
and membrane-bound proteins characterized by the presence of, at
least, one C-type lectin domain (CTLD), some of which act as a
carbohydrate recognition domain (CRD). The fungal cell wall
contains numerous structures like glycans, glycolipids and
glycoproteins that are recognized by several CLR (30) including
Dectin-1 (CLEC7a), Dectin-2 (CLEC6a), Dectin-3 (CLEC4d),
MINCLE (CLEC4e), Mannose Receptor (CD206), DC-SIGN
(CD209), etc (32, 33). Dectin-1 recognizes b-glucans in the cell
wall of diverse pathogenic fungi and is the best-characterized
receptor involved in antifungal immunity. Dectin-1 signaling
involves an immunoreceptor tyrosine-based activation motif
(ITAM)-containing cytoplasmic domain that is phosphorylated by
a Src family kinase that allows Syk kinase recruitment. Dectin-2
recognizes a-mannans and transduces its signal through association
with the ITAM-containing Fc receptor gamma (FcRg) chain (34). In
most CLR signaling, the Syk pathway activates a molecular scaffold
composed by CARD9, Bcl10 and MALT1, which culminates in the
recruitment of several transcription factors including NF-kB and
MAP kinases. Additional intracellular pathways are also induced
and include the Raf-1 kinase pathway and the canonical (NLRP3/
caspase-1) and non-canonical (MALT1/caspase-8) inflammasome
activation pathways (30, 33).December 2020 | Volume 11 | Article 605644
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demonstrated that Dectin-1 and Dectin-2 bind to Microsporum
audouinii and Trichophyton rubrum while Dectin-2 particularly
recognizes high mannose structures or oligo-manosid residues in
the hyphae cell wall. This seminal work described that Dectin-2
couples FcRg chain in RAW cells (human macrophage cell line)
to trigger innate immunity after ligation by fungal hyphae. The
activation of myeloid cells via CLR was further observed in vivo
after T. rubrum intraperitoneal infection of C57BL/6 mice (36,
37). In this setting, WT mice controlled systemic infection at 14
days showing a significant decrease in spleen fungal burden
whereas mice deficient in Dectin-1 or Dectin-2 (Dectin-1 or
Dectin-2 knock-out) and double knock-out (KO) counterparts
were unable to do the same. In addition, other studies showed
that soluble a-mannans (33) and mannose receptor (CD206)
blocking antibody (38) inhibited T. rubrum conidia engulfment
by macrophages in vitro.
In a human disease context, Ferwerda et al. (39) first reported a
family with defective surface expression of mutated Dectin-1 and
susceptibility to chronic vulvovaginal candidiasis and persistent
onychomycosis by T. rubrum. In these patients, peripheral blood
mononuclear cells poorly expressed Dectin-1 and were deficient in
producing tumor necrosis factor (TNF), IL-6, and IL-17, after
stimulation with b-glucans or Candida albicans. According to this,
individuals with inherited deficiencies in CARD9, the CLR
downstream adaptor molecule, are also susceptible to severe
deep dermatophytosis (40).
C-type lectin receptors expression, and its downstream Syk-
CARD9 signaling, is primarily restricted to myeloid cells like
monocytes, macrophages, neutrophils and dendritic cells (30), but it
has also been described in epithelial cells (41) and keratinocytes (42).
Nevertheless, few studies have investigated the role of CLR-expressing
cell populations in the skin during dermatophytosis. In a mouse
model of dermatophyte antigen-induced contact hypersensitivity
(CHS), the percutaneous application of trichophytin (a soluble
antigen from T. mentagrophytes) upregulated Dectin-1 mRNA
(messenger RNA) expression in skin tissue and Dectin-1-expressing
cells were involved in trichophytin-induced CHS (39, 40).
Furthermore, Dectin-1 mRNA expression was up-regulated in
HaCaT cells (a human keratinocyte cell line) co-cultured with
supernatant from T. rubrum culture (43). In contrast, Brasch et al.
(44) studied Dectin-2 expression by immunohistochemistry in
patients with dermatophytosis (tinea corporis) and did not observe
significant differences in Dectin-2 expression in the skin tissue
between patients and healthy control individuals.
Therefore, the current knowledge strongly suggests that
Dectin-1, Dectin-2 and Mannose Receptor expressed on
myeloid cells play a role in triggering the anti-dermatophytic
defense. Nonetheless, the function of particular CLR on skin
cellular subsets driving antifungal response has not been defined
in the context of cutaneous infection yet.NLRP3 Inflammasome and IL-1b
Production in Fungal Infections
IL-1b is a potent inflammatory cytokine mainly produced by
macrophages and neutrophils that promotes cytokine production,Frontiers in Immunology | www.frontiersin.org 5phagocytosis, oxidative burst and neutrophil degranulation. IL-1b
is a cytokine produced as an inactive intracellular precursor
triggered by PPR recognition of microbial pathogen-associated
(PAMPs) or damage-associated (DAMPs) molecular patterns and
later activated into the biologically active form by caspase-
dependent cleavage after inflammasome assembly (45). The core
of the majority of the inflammasomes is the NOD-like receptor
(NLR) and the NLR family pyrin domain-containing 3 (NLRP3) is
the most studied in fungal infections (46). IL-1b production via
the inflammasome canonically requires two signals: the first is
NF-kB-dependent activation provided by microbial binding to
CLR or TLR that induces pro-IL-1b synthesis and NLRP3
transduction. The second signal is given by K+ efflux,
extracellular ATP (adenosine triphosphate), reactive oxygen
species (ROS), fungal toxins, or particulate matter, etc (31).
Consequently, the second signal promotes NLRP3 activation by
triggering the assembly of a multiprotein complex composed of
NLRP3, the adapter protein ASC and the caspase-1 pro-form.
This complex serves as a platform for pro-caspase-1 activation
and, thereby, facilitates proteolytic pro-IL-1b processing to
mature IL-1b (31, 46).
Microsporum canis and Trichophyton schoenleinii hyphae
have been demonstrated to induce IL-1b production by THP-1
cells (a human monocytic cell line) and murine dendritic cells in
a NLRP3 dependent-manner (47, 48). In addition, Dectin-1-Syk-
CARD9 signaling was critical for pro-IL-1b transcription
induced by M. canis, suggesting that dermatophyte glycan
recognition by CLR provides the first signal for NLRP3 and IL-
1b synthesis. Importantly, M. canis also triggered IL-1b
production in vivo, after intraperitoneal infection of WT mice,
but IL-1b release was completely abolished in NLRP3- or ASC-
deficient mice (47). In line with these studies, T. rubrum conidia
phagocytosis also induced IL-1b via Dectin-1 and Dectin-2, in a
NLRP3-ASC-caspase-1 dependent-manner (36) and IL-1 signaling
in macrophages restricted T. rubrum conidia germination and
hyphae growth (37). The second signal proposed for NLRP3
activation and IL-1b release by M. canis or T. schoenleinii was
found to be dependent on cathepsin B activity, K+ efflux and ROS
production. Nevertheless, the dermatophyte-derived molecules
that trigger this second signal remain unknown and, the only
evidence, so far, is that it can be mediated by heat-sensitive
molecules (47, 48). In this sense, dermatophyte heat-sensitive
proteases might play a similar role as the secreted aspartic
proteases (SAPs) from C. albicans which activate NLRP3 after its
internalization via a clathrin-dependent mechanism with
intracellular induction of K+ efflux and ROS production (49).
Taken together, dermatophyte activation of NLRP3
inflammasome via CLR on myeloid cells represents a key event
for triggering innate immunity. Experimental skin infection with
Arthroderma benhamiae, A. vanbreuseghemii (50) or M. canis
(51) elicited IL-1b production by epidermal cells, however, the
role of inflammasome-dependent antifungal immunity during
skin dermatophyte infection is currently unknown.
Toll-Like Receptors
Toll-like receptors (TLR) are membrane glycoproteins that were
first described by their ability to control fungal infections inDecember 2020 | Volume 11 | Article 605644
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response against microbial pathogens. Upon ligand binding, TLR
intracellular signaling is mediated by myeloid differentiation
primary response 88 (MyD88) and TIR domain-containing
adapter-inducer interferon-b (TRIF) to trigger the inflammatory
response. Fungal ligands that bind to TLR are not completely
defined, however, experimental evidence suggests that TLR cross-
signal together with CLR and modulate the antifungal defense (30).
In this regard, it has been demonstrated that TLR-2 increases its
ligand-binding spectrum by heterodimerization with Dectin-1 for
b-glucan recognition (52).
The studies concerning the role of TLR in the anti-
dermatophyte immune response have produced results showing
pro-inflammatory as well as anti-inflammatory effects that need
further elucidation. Myeloid cells, keratinocytes and fibroblasts
increase TLR-2 and TLR-4 mRNA expression upon interaction
with dermatophytes (43, 53). In vitro studies with feline
neutrophils showed an increase in TLR-2 and TLR-4 mRNA
levels after stimulation with live and heat-killed M. canis
arthroconidia (54). Recently, Celestrino et al. (55) reported that
TLR-2 is important for T. rubrum conidia phagocytosis and pro-
inflammatory cytokines production by human monocytes.
Additionally, considering that TLR-2 is not a phagocytic
receptor, these authors suggested that TLR-2 enhances CLR-
mediated phagocytic activity.
Interestingly, extracellular vesicles (EVs) produced by
Trichophyton interdigitale have been demonstrated to induce
proinflammatory mediators by bone marrow-derived
macrophages and keratinocytes in a TLR-2-dependent manner
(22). The EVs are spherical structures composed of a lipid-
bilayer membrane produced by different microorganisms and
play a role in the secretion of virulence factors. Therefore, this
study showed that dermatophytes can modulate the host innate
immune response by producing EVs loaded with still undefined
dermatophyte virulence factors that interact with TLR.
On the other hand, published data using a deep
dermatophytosis model in TLR-2 deficient mice subcutaneously
infected with T. mentagrophytes demonstrated that fungal
interaction with TLR-2 suppresses the inflammatory response of
peritoneal macrophages and the production of IL-17, IL-10 and
IFN-g (interferon-gamma) by splenocytes (56). Coincidentally, we
observed a lower fungal burden in the skin of TLR-2 deficient mice
compared to WT using an epicutaneous model of M. canis
infection (Beccacece I., unpublished data). According to this,
Netea et al. (57) observed that TLR-2 deficient mice were more
resistant to disseminated candidiasis than WT, as there was
increased chemotaxis and enhanced candidacidal capacity of
TLR-2-/- macrophages due to a more robust Dectin-1-mediated
immune response in the absence of TLR-2. Furthermore, TLR-2
expression apparently suppresses Dectin-1-dependent production
of CXCL8 (IL-8) against fungal b-glucans (52, 58). CXCL8 is a
member of the CXCL chemokine family primarily involved in
neutrophil recruitment and activation in response to tissue
damage or infection (59) and can be directly induced in human
keratinocytes by dermatophytes (53, 60).
In patients with dermatophytosis, TLR-2 and TLR-4
immunohistochemical staining was observed in lowerFrontiers in Immunology | www.frontiersin.org 6epidermis from infected skin (44). Accordingly, a recent study
demonstrated that T. benhamiae induced in vitro TLR-2
expression in human keratinocytes and dermal fibroblasts (53).
Thus, so far, there is no clear evidence on the fungal molecules
and mechanisms involved in TLR-dermatophyte interactions
but, as many intracellular signaling molecules are shared
between PRR pathways, it seems that a functionally important
cross-talk with CLR might be crucial for the antifungal response
outcome. The in vivo studies suggest a role of TLR-2 in
downmodulating inflammation during dermatophytosis.DERMATOPHYTE INTERACTION WITH
SKIN CELLS IN THE CONTEXT OF
INFECTION
The stratum corneum, the outer layer of the skin, is composed of
dead keratinocytes, keratin and hydrophobic lipids along with
antimicrobial peptides (AMP), and function as a barrier against
the environment and potential pathogens. In the epidermis,
keratinocytes are essential to initiate the cutaneous immune
response since they express various innate receptors (TLR, CLR,
NLR, etc.) that detect pathogens and induce cytokine, chemokine,
and antimicrobial peptide synthesis to locally modulate the
recruitment and function of inducers and effectors cells from
immunity. Furthermore, keratinocytes express cytokine receptors
(such as IL-17R, IL-22R and TNFR) that potentiate this response. In
between these cells, there are immune cell subsets strategically
located to tissue immunosurveillance like Langerhans cells (LC)
and resident memory CD8+ T cells; while in the dermis, there is a
great variety of cell populations: different subsets of dermal dendritic
cells (DC), macrophages, mast cells, innate lymphoid cells (ILC), gd
T cells and memory-resident and regulatory T cells (CD4+ and
CD8+). Furthermore, there are nervous terminals that innervate the
skin and lymphoid vessels from where immune cells migrate to
lymphoid organs (61) (Figure 2).
Dermatophyte invasion is mostly restricted to keratinized tissues
such as skin, hair, and nails but with the potential to cause extensive
chronic superficial infections or even invasive systemic disease in
immunocompromised patients. Widespread chronic or
extracutaneous invasive infections have been largely related to
patients with keratinization disorders or cell-mediated immunity
deficiencies such as those observed in HIV, bone marrow and solid
organ transplant recipients, or corticosteroid therapy (3, 5). In the
last decade, inherited mutations in key signaling innate immunity
pathways have been related to dermatophytosis susceptibility as
well (40, 62, 63). Considering that our immune system exhibits
tissue-specific restrictions (64) and the majority of results were
obtained usingmyeloid cell populations, we scarcely understand the
cellular and molecular mechanisms involved in the skin immune
response to dermatophytes (Figure 2).
Keratinocytes: Active Initiators of
Cutaneous Immunity Response
The first epidermal cells encountered during the dermatophyte
infection process are keratinocytes (60, 65, 66). Upon exposure toDecember 2020 | Volume 11 | Article 605644
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mediators such as IL-6, CXCL8, TNF, and AMP including
cathelicidin and b-defensins (53, 66, 67). Tani et al. (60)
demonstrated that CXCL8 was detected in supernatants of
24 h co-culture of normal human epidermal keratinocytes
(NHEKs) with microconidia from T. mentagrophytes, T.
rubrum, or T. tonsurans. Cytokine production was strongly
enhanced with the zoophilic T. mentagrophytes, whereas lower
levels were seen with the other anthropophilic species. Moreover,Frontiers in Immunology | www.frontiersin.org 7only T. mentagrophytes induced TNF and granulocyte-
macrophage colony-stimulating factor (GM-CSF) production
by NHEKs. These results support clinical evidence from
human dermatophytosis showing that zoophilic dermatophytes
induce more severe inflammatory responses than anthropophilic
species. As described above for NLRP3 activation in myeloid
cells, heat-killed fungi were unable to induce cytokine
production by NHEKs, suggesting that metabolic activity or
products secreted by dermatophytes are necessary to triggerFIGURE 2 | Model of skin immune response in dermatophytosis. Dermatophyte fungi invade the stratum corneum and release proteases (P) that degrade keratin for
fungal growth and facilitate tissue invasion. Extracellular vesicles (EV) loaded with fungal virulence factors might be also released during infection. Host recognition of
dermatophytes is mainly through CLR and TLR on myeloid cells and keratinocytes. The adapter protein CARD9 is a key molecule in fungal sensing that signals
downstream various CLR and mediates cross-signaling of other innate receptors (TLR and NLR). Keratinocytes (KC) sense fungal hyphae and consequently release:
1) antimicrobial peptides (AMP; including cathelicidin and b-defensin) that are effector molecules promoting fungal clearance, 2) proinflammatory mediators (IL-6,
CXCL8, TNF) that further stimulate inflammation and neutrophil recruitment or 3) immunosuppressive proteins, such as TSG-6, particularly in human infections with
anthropophilic dermatophytes. Also, IL-6, IL-17, and IL-22 further stimulate KC activation. Neutrophils recognize fungi and trigger the intracellular activation of MAPK
and NFkB pathways leading to proinflammatory cytokines/chemokines release that also enhance KC activation, recruit more inflammatory leukocytes and, probably,
promote IL-17 producing-lymphocytes through IL-23 release. Neutrophils also secrete reactive oxygen species (ROS) and neutrophil extracellular traps (NETs) that
kill dermatophytes. The role of macrophages has not been directly evaluated during skin infections but these cells might also kill dermatophytes by IFN-g-induced
ROS and nitric oxide (NO) production or even resolve inflammation through phagocytosis of apoptotic neutrophils with production of anti-inflammatory cytokines
(e.g.: IL-10). As for adaptive immunity, Langerhans cells (LC) are located in the epidermis and sense dermatophytes, migrate to skin draining lymph nodes and
promote Th17 differentiation (ref. 51). Whereas in the dermis, different subsets of dendritic cells (DC) are probably involved in sensing fungal molecules and producing
cytokines that drive IL-17- or IFN-g- mediated immunity. IL-17A produced by adaptive Th17 cells and innate lymphocytes (gdT or ILC) boosts KC activation/
proliferation and inhibits superficial fungal growth. Upon binding to IL-17RA/IL-17RC in KC, IL-17A activates Act1-TRAF6-NFkB/MAPK or STAT-3 intracellular
pathways and induce cytokines/chemokines and AMP production. Furthermore, the IL-17/IL-17RA pathway transactivates epidermal growth factor receptor (EGFR)
which promotes KC proliferation. During mild superficial experimental infection with M. canis, type 17 immunity restricts both fungal growth and an exacerbated type
1 (IFN-g mediated) inflammation (ref. 51). Conversely, IFN-g mediated-response suppresses cytokines related to the IL-17 pathway leading to an increased fungal
burden. During T. benhamiae experimental infection both Th1 and Th17 phenotypes are induced and control the cutaneous mycoses (ref. 120). Dotted lines and
question marks refer to mechanisms not directly demonstrated in the context of skin dermatophytosis. CARD9 signaling might be involved in various skin cells
populations of the antifungal defense. KC, keratinocyte; LC, Langerhans cell; DC, dendritic cell; Ne, neutrophil; ILC, innate lymphoid cell; Mø, macrophages; sdLN,
skin draining lymph node; CLR, C-type lectin receptor; TLR, Toll-like receptor; NLR, nucleotide-binding oligomerization domain (NOD)-like receptor; IL-17RA/IL-
17RC, interleukin 17 receptor A/C; TCR, T cell receptor; MHC, major histocompatibility complex; AMP, antimicrobial peptides; ROS, reactive oxygen species; NO,
nitric oxide; NETs, neutrophil extracellular traps; P, proteases; EV, extracellular vesicles.December 2020 | Volume 11 | Article 605644
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reported by Faway et al. (66) using reconstructed human
epidermis (RHE), an in vitro three-dimensional model of
human skin. After infection with T. rubrum arthroconidia,
hyphae invaded the stratum corneum and located in the whole
intercellular space altering the epidermal barrier integrity and
activating keratinocyte response with mRNA expression and
release of CXCL8, TNF-stimulated gene 6 protein (TSG-6),
AMP (human b-defensin-2 and -3 and S100A7) and, in a
lesser ex tent , IL-1a , IL-1b , TNF, thymic s tromal
lymphopoietin (TSLP), and granulocyte colony-stimulating
factor (G-CSF). In line with these data, Hesse-Macabata et al.
(53) have recently described that T. benhamiae promotes
expression and secretion of pro-inflammatory cytokines/
chemokines as well as expression of various AMP, TLR-2 and
proliferation marker Ki67 after infection of human keratinocytes
and dermal fibroblast.
Taken together, these in vitromodels demonstrate that, in the
absence of immune cells, keratinocytes not only form a physical
barrier against dermatophyte invasion but also actively confer an
early antifungal defense by triggering a skin-specific immune
response (Figure 2). It is worthy to notice that experiments using
reconstructed human epidermis (RHE) also produced high levels
of the immunosuppressive protein TSG-6 after T. rubrum
infection (66), indicating that keratinocytes could also provide
mechanisms involved in inflammation control and tissue
repair (68).
Neutrophils
During dermatophytosis, neutrophils are the first leukocytes
recruited to the site of infection (51, 69) and are thought to be
responsible for fungal elimination from the skin (21, 70, 71)
(Figures 1 and 2). In human infection, as well as in experimental
dermatophytosis models, neutrophils form epidermal
microabscesses surrounding the hyphae in the stratum
corneum (50, 51, 72, 73) (Figure 1). According to this, CD11b+
Ly6G+ neutrophils can be detected by flow cytometry in
epidermal cell suspensions as early as 2 days after M. canis
epicutaneous infection in mice (51). Early studies performed by
Calderon and Hay (70) demonstrated that human peripheral
blood neutrophils exhibited potent cytotoxic activity against T.
quinckeanum and T. rubrum hyphae. Moreover, dermatophyte-
stimulated human neutrophils were able to phagocyte conidia,
produce CXCL8, IL-1b, IL-6, IL-8, and TNF, and stimulate
extracellular traps (NETs) formation (21, 74).
Despite all the experimental evidence suggesting a main role
of neutrophils as the first ‘defenders’ against dermatophytes,
neutropenic patients are not frequently susceptible to
extracutaneous invasive infection as they are to other fungi
(including normally non-pathogenic species) (75). Instead,
neutropenic patients frequently present widespread superficial
infections and dermal granulomas resistant to antifungal
treatment (Majocchi’s granulomas) (76, 77). In agreement with
this, De Sousa et al. (74) studied a cohort of patients with chronic
widespread dermatophytosis without noticeable predisposing
conditions or signs of immunodeficiency and found that their
blood-derived neutrophils and macrophages presented impairedFrontiers in Immunology | www.frontiersin.org 8in vitro killing of T. rubrum. Additionally, neutrophils from
patients displayed defects in hydrogen peroxide, nitric oxide and
cytokine production compared to neutrophils from patients with
typical dermatophytosis (tinea pedis) or healthy donors.
However, this study did not further demonstrate the cause of
antifungal defects showed by the phagocytic cells.
Furthermore, impairment in neutrophil mobilization to the
site of infection or fungal killing mechanisms could be associated
with inherited CARD9 deficiency and dermatophytic disease in
humans (78, 79). Nevertheless, to which extent neutrophils
control cutaneous defenses against dermatophytes and restrain
extracutaneous fungal invasion remains not fully understood.
Antimicrobial Peptides
Antimicrobial peptides and proteins (AMP) are innate immune
effector molecules that not only have microbicidal activity but
also function as chemoattractants and proteinase inhibitors, have
proangiogenic activity, promote wound repair, and can modulate
adaptive immunity. The importance of AMP as antimicrobial
effector molecules relies on fast killing mechanisms like forming
pores in the microbial cell wall or nutrient depletion by
extracellular Zn2+ and Mn2+ chelation (80, 81).
In the skin, there are more than 20 AMP including human b-
defensins (hBDs), cathelicidins (LL-37), S100 proteins, RNase 7
and lactoferrin, among others (82). Keratinocytes constitutively
express hBD1 whereas hBD2, hBD3, and hBD4 require TLR
signaling or induction through TNF, IL-1b, or other cytokines
(83). Additionally, other signaling pathways also regulate AMP
production by keratinocytes, such as insulin-like growth factor 1
(IGF-1), vitamin D signaling and epidermal growth factor
receptor (EGFR) ligands (83). In this regard, EGFR regulates
transcription of downstream AMP genes (hBD-2 and -3, RNase
7, S100A7, elafin) and several cytokines and chemokines
(CXCL8, IL-6, IL-20, IL-24, CXCL1) (80, 82). Keratinocyte
stimulation of G-coupled receptors and certain cytokine
receptors (such as IL-17RA/IL-17RC) results in matrix
metalloproteinase (MMP)-mediated shedding of EGFR ligands
(amphiregulin and heparin-binding epidermal growth factor-like
growth factor, HB-EGF, and transforming growth factor-alpha,
TGF-a) leading to transactivation of EGFR and further AMP
expression in the skin (Figure 2). Strikingly, EGFR blocking in
keratinocytes significantly decreased AMP expression in
response to T. rubrum which could explain the increased
dermatophyte infection rate observed in patients receiving
therapy with anti-EGFR (81).
Lopez-Garcia et al. (84) firstly reported that cathelicidins may
play a role in the skin defense against dermatophytes. They
detected increased cathelicidin protein expression in the skin
from patients with tinea pedis and in vitro inhibition of
Trichophyton sp. growth by cathelicidin-derived synthetic
peptides LL-37 and CRAMP. Similar data were later reported
by Brasch et al. (44), demonstrating that AMP psoriasin
(S100A7), hBD-2 and RNase 7 also inhibit dermatophyte
growth in vitro (85). In agreement, Firat et al. (81) published
that human foreskin-derived keratinocytes exposed to T. rubrum
strongly boosted RNase 7 and hBD-3 expression and this
phenomenon was synergistically increased in the presence ofDecember 2020 | Volume 11 | Article 605644
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expression of epidermal hBD-2 and LL-37 was significantly
lower in Adult T-cell leukemia/lymphoma (ATLL) patients
with dermatophytosis than in infected non-ATLL patients, and
this correlated with a significantly decreased frequency of
peripheral T helper 17 (Th17) lymphocytes and lower IL-17
levels in serum. The ATLL immune condition revealed that Th17
cells are deeply involved in keratinocyte production of
antimicrobial peptides against dermatophytes.TYPE 17 (IL-17-MEDIATED) IMMUNITY IN
DERMATOPHYTOSIS
Type 17 immunity have a critical role in innate and adaptive
immunity at barrier tissues such as oral, intestinal and lung
mucosa as well as the skin. IL-17 cytokines play a major role in
maintaining local homeostasis with microbiota, protecting
against infections and mediating severe inflammatory diseases
such as inflammatory bowel disease or psoriasis (86–88). IL-17
family members comprise six related proteins: IL-17A, IL-17B,
IL-17C, IL-17D, IL-17E (IL-25), IL-17F, and the heterodimer IL-
17AF. Among them, IL-17A has been the most studied cytokine
and, therefore, associated with human health and disease (86).
IL-17A is produced by hematopoietic cells from both innate and
adaptive immune system, including CD4+ T helper (Th17),
CD8+ cytotoxic T (Tc17), gdT, natural killer (NK), group 3
innate lymphoid (ILC3), and ‘natural’ Th17 cells. Members of
the IL-17 family act like “local cytokines”mainly on non-classical
immune cells such as epithelial, endothelial, and fibroblastic cells.
IL-17 signals through heterodimeric receptors composed of the
subunit IL-17RA associated with either IL-17RC, IL-17RE, or IL-
17RB, which are specifically stimulated by IL-17A and F, IL-17C,
and IL-17E (IL-25), respectively (89). Upon signaling on
keratinocytes, IL-17 stimulates the production of various
cytokines (such as GM-CSF, TNF, IL-6), chemokines (CXCL1,
CXCL8), and vascular endothelial growth factor (VEGF). IL-17
can also enhance the expression of AMP such as hBD-2 and LL-
37 and promote keratinocyte proliferation (80). All these
mechanisms may play a major role in clearing cutaneous
fungal infection (90, 91) (Figure 2).
In the skin, fungal recognition by PRR on myeloid cells (DC,
macrophages, neutrophils) and, probably, keratinocytes and
fibroblasts trigger the production of cytokines like IL-23, IL-6, IL-
1b, and IL-21 (51, 53, 90). Cytokine binding to its receptor on
lymphocytes selectively triggers intracellular Signal Transducer and
Activator of Transcription 3 (STAT3) phosphorylation, Retinoic-
acid-receptor-related orphan nuclear receptor gamma (RORgt)
transcription factor activation and, eventually, leads to the
induction of Th17 lineage or the synthesis of type 17-cytokines
(IL-17, GM-CSF, IL-22) (92). Noteworthily, IL-17A can also
activate STAT3 in keratinocytes and amplify IL-6 production (80)
(Figure 2). In line with this, patients with STAT3 mutations
(Autosomal dominant hyperimmunoglobulin E syndrome, AD-
HIES) have increased susceptibility to candidiasis and
dermatophytosis due to a diminished Th17 response (62).Frontiers in Immunology | www.frontiersin.org 9It is well known that mucocutaneous candidiasis (CMC), a
chronic and recalcitrant clinical syndrome, is associated with
several genetic diseases related to dysregulation or inhibition of
the IL-23/IL-17 pathway (33, 93). In this sense, IL-17-producing
memory CD4+ T cells in peripheral blood expand specifically upon
Candida albicans stimuli (94) and skin resident Th17 lymphocytes
mediate protective immunity to this yeast (95). However, much less
is known about the skin T cell response during dermatophytosis.
Deficiencies in type 17 immunity associated with susceptibility to
widespread chronic dermatophytosis have been reported in patients
with ATLL (67), autoimmune polyendocrinopathy-candidiasis-
ectodermal dystrophy (APECED) (72), Dectin-1 mutations (39),
loss-of-function mutations in STAT3 (62), autosomal gain-of-
function mutations in STAT1 (96, 97), and anti-IL-17 antibody
treatment (secukinumab) (73, 98). Furthermore, IL-17 impairment
was also associated with inherited CARD9 deficiency and deep
dermatophytosis (40, 99).EXPERIMENTAL DERMATOPHYTOSIS AS
MODELS OF HUMAN DISEASE
In contrast to research on Candida sp. infection, the lack of
murine experimental models for dermatophytosis that mimic
natural human infection long-hindered the possibility of in-
depth studies on immunological mechanisms involved in the
susceptibility to these mycoses. In the 1980s, Hay et al. (100, 101)
made important contributions to the understanding of the anti-
dermatophytic immunity by developing a highly inflammatory
dermatophytosis model, similar to favus in humans, after
epicutaneous infection of BALB/c mice with the murine
pathogen T. quinckeanum. They showed that mice self-
controlled the infection with a peak of skin lesions at 7–10
days, characterized by epidermal proliferation (acanthosis),
neutrophil recruitment (epidermal microabscesses) and
increased antigen-specific lymphocyte proliferation (69).
Furthermore, they found that the adoptive transfer of T
lymphocytes conferred resistance to sub-lethally irradiated
mice (101) and that immunological memory was evidenced in
re-infected mice (secondary infection) as they quickly cleared
fungi and showed an augmented lymphoproliferative response to
fungal antigens (100).
After almost 30 years of the studies published by Hay and
colleagues, in 2014, Cambier et al. (50) developed a similar model
in C57BL/6 mice with the zoophilic species Arthroderma
benhamiae and A. vanbreuseghemii (both from the
Trichophyton mentagrophytes complex) that cause highly
inflammatory dermatophytosis in humans (102, 103). In this
regard, experimental models of human diseases developed in a
C57BL/6 mice background are remarkably important for the
study of immunological mechanisms due to the wide variety of
genetically modified strains available (104). Mice epicutaneously
infected with Arthroderma self-healed at approximately 30 days
with a clinical course and features similar to the inflammatory
dermatophytosis in humans (50). Interestingly, Arthroderma-
infected skin showed mRNA overexpression of proinflammatoryDecember 2020 | Volume 11 | Article 605644
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IL-6, and IL-22 at days 7 and 21 post-infection, suggesting a role
of type 17-immunity in host defense. In this line, we later
demonstrated that IL-17-mediated immunity is key for host
protection in an experimental epicutaneous infection of
C57BL/6 mice with Microsporum canis (51), a zoophilic
dermatophyte that causes highly prevalent tinea capitis and
tinea corporis in children (105–107) (Figure 1). Similarly to
the Arthroderma model, M. canis-infected mice showed skin
lesions only limited to the epidermis and hair follicles, with a
maximal clinical score at 8 days post-infection and fungal
clearance around day 28. However, in contrast to that observed
in Arthroderma-infected mice, M. canis infection was
characterized by mild cutaneous lesions resembling non-
inflammatory human disease (Figure 1). Re-stimulation of
skin draining lymph node cells with heat-killed M. canis
showed that Th17 adaptive immunity predominates during
infection (51). As demonstrated for Candida and Malassezia
(108, 109), M. canis selectively triggers a type 17 immune
response mainly by CD4+T and, to a lesser extent, by CD8+T
lymphocytes in lymph nodes around 8 days post-infection.
Furthermore, IL-17-deficient mice (IL-17RA KO or IL-17A/F
KO) were extensively colonized with M. canis hyphae as
demonstrated by a forty-fold increase in skin fungal burden
compared to WT infected mice (Figure 1). IL-17-deficient mice
showed less epidermal thickening (acanthosis) nevertheless, pro-
inflammatory cytokine production was up-regulated after
infection. Moreover, in the absence of a functional IL-17
pathway, M. canis did not invade dermis or deep tissues in
mice (51) in coincidence with clinical evidence showing that
humans with deficiencies in type 17 immunity or treated with
anti-IL-17 antibody (secukinumab) are susceptible to widespread
superficial infections rather than deep dermatophytosis (67, 73).
Strikingly, in our model, neutrophil function and
mobilization to the site of infection were uncoupled from IL-
17 signaling since IL-17-deficient mice had a significantly higher
frequency of neutrophils in the skin (51) (Figure 1). Supporting
these findings, neutrophilic microabscesses were observed next
to hyphae in the epidermis of a patient with dermatophytosis
after 4 weeks of treatment with anti- IL-17 antibody (73). Further
research is needed to establish the in vivo role of neutrophils in
dermatophytosis and the molecular pathways driving its
mobilization to the skin. Considering that dermatophytes
induce a robust production of chemokines and cytokines
(CXCL8, CXCL1, IL-6) by keratinocytes (53, 60, 65, 110), these
chemotactic factors are probably the main mediators of
neutrophil recruitment, independently of IL-17 signaling.
Altogether, these experimental and clinical results reveal that
type 17 immunity is important to boost keratinocyte
proliferation and probably early production of AMP after
dermatophyte skin invasion. Eventually, IL-17 deficient hosts
are able to overcome infection but at the expense of an
exacerbated inflammation and tissue damage (51, 111).
On the other hand, anthropophilic dermatophytes (e.g. T.
rubrum, T. interdigitale, T. tonsurans) are evolutionarily adapted
to human keratin and consequently, murine experimentalFrontiers in Immunology | www.frontiersin.org 10models might have limitations in recapitulating the features of
inflammation and specific immune response occurring in a
natural setting. Nevertheless, Baltazar et al. (112) have reported
some interesting data by developing a model of T. rubrum
infection in C57BL/6 mice after epicutaneous and intradermal
inoculation of conidia. Likewise to theM. canismodel, T. rubrum
infected mice showed a peak of fungal burden after 7 days of
infection (112) that significantly decreased by day 14. Along with
T. rubrum infection, myeloperoxidase (MPO) and N-
acetylglucosamine (NAG) activity was detected in the skin,
suggesting recruitment of neutrophils and macrophages to the
site of infection. Interestingly, MPO activity decreased in parallel
with fungal load (14 days post-infection), but NAG activity
remained elevated, even after fungal clearance (112). The
authors hypothesized that skin macrophages might be involved
not only in fungal killing, but also in the resolution of
inflammation. In this sense, phagocytosis of apoptotic
neutrophils by macrophages is a key mechanism to down-
modulate inflammation and return to tissue homeostasis
during infectious diseases (113) (Figure 2).TYPE 1 (IFN-G-MEDIATED) IMMUNITY
The role of IFN-g-mediated (type 1 or Th1) response in
protective skin immunity against dermatophytes remains less
clear than IL-17-driven immunity. In the M. canis model,
dermatophyte infection in WT mice did not trigger the
expansion of antigen-specific IFN-g-producing T cells in skin
draining lymph nodes (51). In contrast, IL-17-deficient mice
experienced a shift to a type 1 response suggesting the
establishment of IFN-g-mediated compensatory mechanisms to
restraint M. canis infection. Nonetheless, in vivo IFN-g
neutralization in IL-17RA KO mice (at days 3 and 6 post-
infection) increased skin production of Th17-lineage cytokines
(IL-22, IL-17, IL-1b, IL-6) and significantly inhibited fungal
growth (51). These surprising data open the possibility that
IFN-g deregulation, in the absence of IL-17 signaling, might
contribute to superficial M. canis overgrowth by inhibiting type
17-related responses. However, the mechanisms by which Th1
cytokines may interfere with cutaneous immunity against
dermatophytes and counter-regulate the IL-17 pathway remain
unknown. Therefore, in this model, type 17 immunity has a dual
role during infection by inhibiting dermatophyte growth and
controlling Th1-mediated inflammation (51, 111).
In line with the experimental data observed in the M. canis
mouse model, patients with mutations that lead to the gain of
function in the transcription factor STAT1 (STAT1 GOF), that
promote type I and type II IFN genes transcription, have reduced
type 17 immunity and are susceptible to chronic mucocutaneous
candidiasis (CMC) and dermatophytosis (96, 97, 114–117).
Consistent with this, increased STAT1 responses to Th1
cytokines (IFN-g and IL-27) were shown to repress the
differentiation of IL-17-producing T cells through mechanisms
that are not yet completely understood (114, 118). In fact,
increased STAT1 phosphorylation induced by IFN-g can beDecember 2020 | Volume 11 | Article 605644
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ruxolitinib (113) and, interestingly, patients with STAT1 GOF
condition treated with ruxolitinib have shown remission of
mucocutaneous candidiasis (119). Altogether, the clinical data
supports the experimental results from M. canis model (51),
showing that dermatophyte susceptibility is mainly due to
deficiencies in IL-17-driven immunity and that type 17 and
type 1 immunity would eventually counter-regulate each other.
Nevertheless, Heinen et al. (120) observed that, after
Trichophyton benhamiae epicutaneous infection in C57BL/6
mice, Th17 along with Th1 responses function in a
complementary manner and, only when both IL-17 and IFN-g
pathways are deficient, mice suffer from superficial persistent
infection. In contrast, Baltazar et al. (112) reported that IL-12p40
KO mice (lacking common b-subunit of IL-12 and IL-23 and thus,
with impaired IL-17 and IFN-g signaling) or IFN-g KO mice were
able to control T. rubrum infection after 14 days, but showed an
increased fungal burden in the first week compared to infectedWT
mice. Eventually, as described for the M. canis model (51), deep
dermatophytosis was not observed in the absence of IL-17 and
IFN-g in neither infection models (112, 120), suggesting that
several immune pathways must be compromised to establish
invasive dermatophytosis. The effector mechanisms of IFN-g
remains unclear but Verma and Gaffen (121) hypothesized that,
as observed in Candida skin infection, IFN-g may contribute to T.
benhamiae destruction and expulsion by activating the fibrinolytic
system in the epidermal abscess (122) or promoting M1
macrophages at a later infection stage (Figure 2). In line with
this, peritoneal macrophages from IFN-g KO mice showed
decreased ROS production and were unable to efficiently
phagocyte and kill T. rubrum conidia in vitro (112) indicating
that macrophages might play a role in clearing infection.
The most noticeable difference between theM. canis (51) and
the T. benhamiae (120) model is that mice infected with T.
benhamiae had a more aggressive infection with significantly
augmented fungal burden and skin inflammation, compared to
M. canis-infected mice. Therefore, undefined specific virulence
factors produced by these two pathogens may selectively activate
different immune pathways in the skin. In addition, the route of
infection in the T. rubrum model (intradermal conidia
inoculation) might activate specific subsets of dermal dendritic
cells that could eventually promote IFN-g-mediated response
(112) (Figure 2). This was observed in Candida albicans skin
infection, where epicutaneous infection induces Th17 response
through Langerhans cells (LC), while invasive Candida hyphae
in dermis triggers Th1 immunity mediated by CD103+ dermal
dendritic cells (108).
In conclusion, the experimental data confirm clinical
evidence showing that type 17 immunity is crucial for
preventing uncontrolled superficial dermatophyte growth and
for restricting an exacerbated cutaneous inflammation. The
function of type 1 immunity is less clear since it inhibits type
17-mediated protective mechanisms (in the absence of an
optimal IL-17 signaling) as observed in the mild inflammatory
M. canis model or, in contrast, it might contribute to clear the
infection as observed in the T. benhamiae inflammatory model.Frontiers in Immunology | www.frontiersin.org 11SKIN ANTIGEN-PRESENTING CELLS AND
INNATE VERSUS ADAPTIVE RESPONSE
In the steady-state skin, there is a coexistence of several antigen-
presenting cells (APC) with the capacity to initiate and shape the
immune response against pathogens. Langerhans cells are the most
abundant population of skin APC and are constitutively localized in
the epidermis. Other major populations of migratory skin DC are
present within the dermis: CD103+ DC subset, CD11b+ DC (CD1c+
DC in humans) and double negative DC. The current consensus is
that these defined DC subsets contribute differently to antimicrobial
immunity depending on the pathogen, the site or the stage of
infection (123). The paradigm of adaptive immunology poses that
after pathogen invasion, skin DC capture antigens and migrate to
lymph nodes to present them to T lymphocytes in an MHC-TCR
(Major Histocompatibility Complex–T cell receptor) context,
thereby expanding antigen-specific T helper or T regulatory
clones which return to the skin to fight the infection and
modulate inflammation, respectively. In Candida albicans or
Malassezia epicutaneous infections, IL-6- or IL-23-producing LC
migrate and induce an antigen-specific Th17 response by 7–10 days
post-infection (90, 109). At the same time, cutaneous DC are also
able to rapidly and locally activate resident skin cells to arm the
innate immune response. Notably, C. albicans directly stimulates
sensory neurons to produce a neuropeptide that, in turn, induces
IL-23 production by dermal DC and promotes a rapid protective
response by IL-17-producing gdT cells (124). Moreover, as early as 2
days during Malassezia infection, not only LC but also neutrophils
produced IL-23 to stimulate IL-17A-production by gdT, ILC and
abT cells in the skin (109). Nonetheless, the precise mechanisms
involved in the induction of protective immunity in
dermatophytosis are far less clear. Type 17 immunity-instructing
factors IL-1b, IL-6, TGF-b and IL-23 were produced by epidermal
cells afterM. canis and T. benhamiae dermatophytosis in mice (51,
120). In theM. canismodel, langerin expressing-dendritic cells (LC
and a minor population of dermal DC) contributed critically to the
regulation of theM. canis-specific Th17 response in draining lymph
nodes (51), which is reminiscent of Th17 induction in response to
epicutaneous infection with C. albicans (125) andMalassezia (109).
However,M. canis fungal burden was not affected by fungal-specific
Th17 cell reduction after depletion of langerin-expressing DC (51),
pointing towards alternative innate sources of IL-17 for controlling
dermatophytosis (Figure 2). In this sense, Heinen et al. (120)
observed that IL-17 mRNA expression was early induced (3 days
post-infection) in the skin ofT. benhamiae-infectedmice and showed
a remarkably strong contribution of innate immunity in clearing
dermatophytes from the skin. They demonstrated that Rag2-/- mice
(lacking T and B cells) presented a long-lasting infection but were
ultimately able to clear T. benhamiae from the skin.INHERITED CARD9 DEFICIENCY AND
DEEP DERMATOPHYTOSIS
The clearest evidence of innate immunity involvement in
restricting dermatophyte extracutaneous invasion was theDecember 2020 | Volume 11 | Article 605644
Burstein et al. Skin Antifungal Immunitydiscovery of loss-of-function mutations in the adapter protein
CARD9 as the primary immunodeficiency underlying deep
dermatophytosis (126). Deep dermatophytosis is a severe,
recalcitrant and, sometimes, a life-threatening infection
characterized by extensive invasion of the dermis (106) (Figure
1), hypodermis, and deeper tissues, by dermatophytes (6). As
described above, CARD9 is a caspase recruitment domain-
containing signaling protein crucial for CLR downstream
signaling and gene activation by fungal glycans but it is also
involved in cross-signaling with other innate receptors, such as
TLR and NLR (107). Thus, CARD9 protein plays a critical role in
innate immunity probably controlling various innate immune
pathways (Figure 2).
In 2013, Lanternier et al. (40) first demonstrated that 17 non-
consanguineous patients with deep dermatophytosis by T.
rubrum or T. violaceum, had autosomal recessive CARD9
deficiency without other associated infectious conditions, except
oral candidiasis in six of them. These authors described two CARD9
mutations: a homozygous premature stop codon mutation (Q289),
identified in 15 patients from seven unrelated Algerian and
Tunisian families, and a homozygous missense mutation (R101C)
in two Moroccan siblings. The functional consequence of CARD9
mutations was a markedly low level of IL-6 production after
stimulation of whole-blood leukocytes with heat-killed C. albicans
or S. cerevisiae, but not with TLR agonists. Furthermore, peripheral
Th17 cells from CARD9-deficient patients were significantly less
frequent than healthy controls. CARD9 Q289 mutation was later
described in Egyptian patients with widespread superficial T.
rubrum infection of the skin and nails without significant visceral
involvement (127). Recently, this mutation was also reported in an
Algerian woman who suffered from cutaneous chronic
dermatophytosis by T. rubrum from her childhood and developed
an invasive brain infection in her adulthood (128).
The phenotypic variability of dermatophytic infection
observed in patients with CARD9 deficiency ranges from
extensive skin and nail lesions to potentially lethal lymph node
and central nervous system infection. In 2015, Grumach et al.
(129). reported a Brazilian patient with deep dermatophytosis by
T. mentagrophytes harboring a novel CARD9 mutation, R101L.
The patient displayed impaired fungal killing by neutrophils and
low numbers of CD16+/CD56+ NK cells in peripheral blood.
Similarly, Alves de Medeiros et al. (130) described a homozygous
R70W CARD9 mutation in a Turkish family with resistant
chronic cutaneous and deep dermatophytosis along with
mucocutaneous and invasive candidiasis. In these patients,
circulating IL-17 and IL-22 producing T cells were decreased
as well as IL-6 and GM-CSF secretion by peripheral
mononuclear cells upon stimulation with Candida albicans.
Furthermore, high levels of serum IgE and eosinophilia were
also a feature in all patients with CARD9 deficiency and invasive
fungal invasion, but the link of these responses with the absence
of CARD9 remains unexplained so far (40, 127, 130).
The cellular and molecular pathways related to CARD9
signaling in the skin have been scarcely investigated (131, 132)
and it is currently unknown how CARD9 precisely drives
cutaneous antifungal immunity (Figure 2). The accumulatingFrontiers in Immunology | www.frontiersin.org 12evidence in humans has shown, so far, that susceptibility to
fungal diseases in CARD9-deficient patients is related to the poor
production of inflammatory cytokines by myeloid cells in
response to fungal antigens along with an impairment in type
17-mediated immunity (126). Furthermore, CARD9 signaling
was required in tissue-resident cells for an appropriate induction
of CXC chemokines for neutrophil recruitment to the site of
fungal infection (79). Noteworthily, Queiroz-Telles et al. (78)
have recently reported a successful allogeneic hematopoietic
stem cell transplantation (HSCT) in two patients with
inherited CARD9 deficiency and deep dermatophytosis. More
than 3 years after HSCT, both patients have achieved complete
clinical remission and stopped antifungal therapy. This evidence
points toward deep dermatophytosis pathogenesis in CARD9-
deficiency settings might be largely due to the disruption of
myeloid cell antifungal response.CONCLUSIONS AND FUTURE
DIRECTIONS
Over the last years, remarkable progress has been made for
immunity to fungal pathogens while the physiopathogenesis of
dermatophytosis remains poorly explored. So far, clinical and
experimental evidence shows that type 17 immunity controls
superficial infection, probably by promoting antimicrobial
peptide production and keratinocyte proliferation, and
independently of early recruited neutrophils with fungicidal
function at the site of infection. Additionally, in the setting of
mild inflammatory infections, IL-17-mediated response would
be crucial to control cutaneous homeostasis preventing detrimental
Th1 inflammation. The susceptibility to extracutaneous deep
dermatophytosis would be related to deficiencies in various
immunity pathways converging in CARD9 activation and
probably restricted to the myeloid cell compartment.
In addition to causing symptomatic infections with different
severity degrees (Figure 1), dermatophytes also colonize 30%–
70% of the human population without causing clinical disease (1,
2, 133), thus these keratin parasites could be considered as a
component of the human microbiota. Strikingly, the presence of
dermatophyte in the skin, either in commensal or pathogenic
relationship with susceptible hosts, has been related to asthma,
allergy or eczematous skin (5, 13, 134). Therefore, the
colonization of the skin by dermatophytes is an interesting
concept to explore for its potential ability to induce migratory
or tissue-resident immune cells that could participate in
inflammatory pathological settings.
The increasing dermatophytosis incidence in certain
geographic areas, the growing evidence of susceptible hosts
with severe clinical presentations and the emerging antifungal
resistance (7, 33, 135) highlight the need for a deeper
understanding of the dermatophyte-host interaction. The next
challenges are thoroughly defining which are the virulence
factors responsible for dermatophyte pathogenesis and the
mechanisms involved in limiting the infection, or, otherwise,
those favoring chronicity or asymptomatic colonization.December 2020 | Volume 11 | Article 605644
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